Seeing Is Believing

Currently out of the existing stock ratings of Whit Mayo, 140 are a BUY (53.23%), 111 are a HOLD (42.21%), 12 are a SELL (4.56%).
Analyst Whit Mayo, currently employed at LEERINK, carries an average stock price target met ratio of 75.23% that have a potential upside of 21.43% achieved within 234 days.
Whit Mayo’s has documented 524 price targets and ratings displayed on 36 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on MD, Mednax at 04-Sep-2025.
Analyst best performing recommendations are on EHAB (ENHABIT).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 11/8/2022. The price target of $1.5 was fulfilled within 3 days with a profit of $0.21 (16.28%) receiving and performance score of 54.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$35
$11.61 (49.64%)
$55
21 days ago
(07-Oct-2025)
3/7 (42.86%)
$9.4 (36.72%)
220
Hold
$25
$1.61 (6.88%)
$52
22 days ago
(06-Oct-2025)
3/9 (33.33%)
$-2.23 (-8.19%)
90
Buy
$30
$6.61 (28.26%)
$100
26 days ago
(02-Oct-2025)
9/11 (81.82%)
$2.86 (10.54%)
553
Hold
$22
$-1.39 (-5.94%)
$32
2 months 15 days ago
(13-Aug-2025)
19/24 (79.17%)
$1.34 (6.49%)
76
Buy
$28
$4.61 (19.71%)
$43
2 months 16 days ago
(12-Aug-2025)
0/10 (0%)
$7.23 (34.81%)
Which stock is Whit Mayo is most bullish on?
Which stock is Whit Mayo is most reserved on?
What Year was the first public recommendation made by Whit Mayo?